Position in AZN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,271,246
-$203,186 QoQ
Shares Held
27,799
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#390
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bryn Mawr Trust Advisors, LLC holds $73,679,493 across 10 Drug Manufacturers - General names. AZN ranks #3 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
220,148 | $28,289,018 | |
| 2 | JNJ |
Johnson & Johnson
|
107,673 | $27,345,711 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
27,799 | $5,271,246 | |
| 4 | LLY |
ELI LILLY & Co
|
3,407 | $4,086,458 | |
| 5 | AMGN |
Amgen Inc
|
9,560 | $3,461,867 | |
| 6 | ABBV |
AbbVie Inc.
|
8,879 | $2,234,311 | |
| 7 | PFE |
Pfizer Inc
|
49,991 | $1,203,783 | |
| 8 | NVS |
Novartis AG
|
5,909 | $926,058 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,271,246 | 27,799 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $5,474,432 | 27,758 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||